HCPLive Network

CDC Warns of New Strain of Virus Responsible for Most Cases of Gastroenteritis

 
THURSDAY, Jan. 24 (HealthDay News) -- A novel strain of norovirus, GII.4 Sydney, which was first detected in Australia in March of last year, was responsible for the majority of norovirus outbreaks in the United States from September through December 2012, according to a report published in the Jan. 25 issue of the U.S. Centers for Disease Control and Prevention's Morbidity & Mortality Weekly Report.

Leslie Barclay, from the CDC in Atlanta, and colleagues analyzed 2012 CaliciNet data on norovirus activity to determine the prevalence of GII.4 Sydney-associated outbreaks in the United States.

The researchers noted 266 reported outbreaks of norovirus, which is highly contagious and causes acute gastroenteritis, leading to nausea and vomiting. Of these cases, 141 (53 percent) were caused by the new strain.

"GII.4 noroviruses remain the predominant cause of norovirus outbreaks, and the GII.4 Sydney strain appears to have replaced the previously predominant strain, GII.4 New Orleans. Compared with other norovirus genotypes, GII.4 noroviruses have been associated with increased rates of hospitalizations and deaths during outbreaks," the authors write. "Health care providers and public health practitioners should remain vigilant to the potential for increased norovirus activity in the ongoing season related to the emergent GII.4 Sydney strain."
 

Full Text


Copyright © 2013 HealthDay. All rights reserved.
 
 

Further Reading
Even though the active ingredient in marijuana can be associated with memory impairment, it may slow or halt Alzheimer’s disease.
The costs of Medicare associated with Sovaldi (sofosbuvir), an emerging hepatitis C drug, will vary depending on how many people are given the treatment, a blog in Health Affairs found.
For patients with cancer, factors associated with late admission to hospice have been identified, according to a study published online Aug. 25 in the Journal of Clinical Oncology.
Healthcare practices continue to suffer from embezzlement problems. While there is no such thing as a perfect system to prevent embezzlers, there are ways to deter them.
Revised guidelines recommend athletes to drink when they are thirsty and to supplement post-training fluids with “recovery foods.”
Gastroparesis, or delayed gastric emptying, remains misunderstood despite rising prevalence, according to a news release from the International Foundation for Functional Gastrointestinal Disorders (IFFGD), a nonprofit research and education organization addressing issues surrounding gastrointestinal and motility disorders.
The European Commission (EU) has granted Bristol-Myers Squibb’s Daklinza (daclatasvir) approval for an all-oral drug regimen for the treatment of four genotypes of chronic hepatitis C infection.
More Reading